Какова цена за Bora Pharmaceuticals Co., Ltd. (6472)

Цена за Bora Pharmaceuticals Co., Ltd. (6472) Это $13.96

Какова рыночная капитализация для Bora Pharmaceuticals Co., Ltd. (6472)

Рыночная капитализация для Bora Pharmaceuticals Co., Ltd. (6472) Это $1.78B

Bora Pharmaceuticals Co., Ltd. (6472) Операционная маржа

Globally, Bora Pharmaceuticals Co., LTD. is engaged in the comprehensive lifecycle of pharmaceutical products, encompassing research and development, manufacturing, distribution, and sales. The organization operates through key divisions, including Sales, Contract Development & Manufacturing Organization (CDMO), and other ancillary services. Bora produces and markets a diverse range of medicines, from generic and proprietary brand-name drugs to over-the-counter (OTC) remedies. Beyond its in-house portfolio, the company provides extensive contract development and manufacturing solutions. These CDMO services cover all stages of pharmaceutical development, clinical and commercial production, specialized packaging and serialization, rigorous analytical and microbiological quality control, and expert guidance on regulatory compliance. Furthermore, Bora's offerings extend to nutritional supplements, skincare products, and various biotechnical services. The company distributes its goods directly to healthcare facilities such as clinics, pharmacies, and pharmacy chains, as well as to drugstores. It also leverages distributors to supply larger institutions like medical centers, corporate and public hospitals, and regional and district hospitals. Established in 2007, Bora Pharmaceuticals Co., LTD. is based in Taipei City, Taiwan.

Год	Операционная маржа	Изменить
Недостаточно данных для указанных дат.

Год

Операционная маржа

Изменить

Недостаточно данных для указанных дат.

Компания	Операционная маржа	Разница в операционной марже	Страна
MERCK Kommanditgesellschaft auf Aktien MER.SW	0.00%	-	DE
Merck KGaA MRK.DE	0.00%	-	DE
Takeda Pharmaceutical Company Limited 4502.T	0.00%	-	JP
Galderma Group AG GALD.SW	0.00%	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	22.93%	-	IN

Компания

Операционная маржа

Разница в операционной марже

Страна